Internal Medicine, Rheumatology · Torrance, CA
NPI
1366548646
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
21840 Normandie Ave, Ste. 700
Torrance, CA, 90502
Phone (310) 222-5101
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
9,138 services
Medicare patients, 2024
327
Average age 75
Drug cost, 2024
$2.0M
1,917 prescriptions
Company payments, 2025
$530
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dilrukshie Cooray was code J0897 (injection, denosumab, 1 mg), 5,520 times for 56 patients. In total Dilrukshie Cooray billed 9,138 services in 16 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,520 | 56 | $20.66 | $114K |
| 99214 Office E&M - Established | Office | 542 | 263 | $99.04 | $54K |
| 96372 Injection Administration | Office | 152 | 80 | $12.32 | $1,873 |
| 99204 Office E&M - New | Office | 78 | 78 | $132.16 | $10K |
| 99215 Office E&M - Established | Office | 45 | 37 | $140.61 | $6,327 |
| 99213 Office E&M - Established | Office | 25 | 25 | $72.25 | $1,806 |
By year: 2022 $158K for 8,990 services; 2023 $180K for 8,109 services; 2024 $211K for 9,138 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dilrukshie Cooray prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 350 prescriptions and refills. In total Dilrukshie Cooray wrote 1,917 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 350 | 874 | 97 | $16K |
| Prednisone Generic | 272 | 466 | 68 | $2,183 |
| Methotrexate Methotrexate Sodium | 130 | 260 | 34 | $3,100 |
| Prolia Denosumab | 86 | 510 | 51 | $148K |
| Leflunomide Generic | 71 | 181 | 25 | $7,470 |
| Allopurinol Generic | 62 | 195 | 18 | $806 |
| Folic Acid Generic | 52 | 146 | 18 | $359 |
| Colchicine Generic | 50 | 141 | 21 | $3,804 |
| Omeprazole Generic | 49 | 111 | 16 | $607 |
| Alendronate Sodium Generic | 49 | 137 | 23 | $465 |
| Gabapentin Generic | 46 | 122 | 13 | $965 |
| Sulfasalazine Generic | 45 | 92 | 12 | $1,337 |
| Orencia Clickject Abatacept | 44 | 59 | Under 11 | $346K |
| Mycophenolate Mofetil Generic | 40 | 64 | Under 11 | $3,671 |
| Amlodipine Besylate Generic | 33 | 87 | 11 | $229 |
Brand drugs: - claims; generic drugs: 1,538 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dilrukshie Cooray $530 ($530 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $171.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.